Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

909 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Safety of low dose efavirenz regimen in Indian adults with HIV-1 infection: Insights from a phase 4 interventional randomised trial.
Dravid AN, Pilawan AS, Anuradha S, Morkar DN, Ramapuram JT, Madhukarrao KM, Naik KS, Bhrusundi M, Raveendra KR, Nageswaramma S, Kulkarni V. Dravid AN, et al. Among authors: kulkarni v. Medicine (Baltimore). 2023 Nov 3;102(44):e35643. doi: 10.1097/MD.0000000000035643. Medicine (Baltimore). 2023. PMID: 37933062 Free PMC article. Clinical Trial.
Efficacy and safety of 400 mg efavirenz versus standard 600 mg dose when taken with tenofovir and lamivudine combination in Indian adult patients with HIV-1 infection: An open-label, interventional, randomized, non-inferiority trial.
Dravid A, Pilawan AS, S A, Morkar DN, Ramapuram JT, Madhukarrao KM, Naik KS, Bhrusundi M, K R R, Nageswaramma S, Kulkarni V. Dravid A, et al. Among authors: kulkarni v. Medicine (Baltimore). 2022 Dec 2;101(48):e31982. doi: 10.1097/MD.0000000000031982. Medicine (Baltimore). 2022. PMID: 36482530 Free PMC article. Clinical Trial.
SARS-CoV-2 recombinant spike ferritin nanoparticle vaccine adjuvanted with Army Liposome Formulation containing monophosphoryl lipid A and QS-21: a phase 1, randomised, double-blind, placebo-controlled, first-in-human clinical trial.
Ober Shepherd BL, Scott PT, Hutter JN, Lee C, McCauley MD, Guzman I, Bryant C, McGuire S, Kennedy J, Chen WH, Hajduczki A, Mdluli T, Valencia-Ruiz A, Amare MF, Matyas GR, Rao M, Rolland M, Mascola JR, De Rosa SC, McElrath MJ, Montefiori DC, Serebryannyy L, McDermott AB, Peel SA, Collins ND, Joyce MG, Robb ML, Michael NL, Vasan S, Modjarrad K; EID-030 Study Group. Ober Shepherd BL, et al. Lancet Microbe. 2024 May 15:S2666-5247(23)00410-X. doi: 10.1016/S2666-5247(23)00410-X. Online ahead of print. Lancet Microbe. 2024. PMID: 38761816 Free article.
909 results